EndoTODAY | EndoATLAS | OPD

Parasite | Eso | Sto | Cancer | ESD

Boxim | DEX | Sono | Schedule

Home | Recent | Blog | Links


[À§¾Ï 251 - Mantle cell lymphoma]

Previous | Next

001 | 101 | 201 | 301 | 401 | 501 | 601 | 701 | 801 | 901 | 1000


1. Mantle zoneÀº ¾îµðÀΰ¡? Mantle cell lymphomaÀÇ Á·º¸´Â?


2. Mantle cell lymphomaÀÇ ÀÓ»óÀû Ư¡

°¡Àå Áß¿äÇÑ Æ¯Â¡Àº óÀ½ ¹ß°ß½Ã systemic diseaseÀÎ °æ¿ì°¡ ´ëºÎºÐÀ̶ó´Â °ÍÀÔ´Ï´Ù. À§Àå°üµµ ´ëºÎºÐÀÇ °æ¿ì¿¡ ÀÌ¹Ì Ä§À±µÇ¾î ÀÖ´Ù°í ÇÕ´Ï´Ù (World J Gastroenterol. 2010).

1) Subtype of B cell NHL

2) Typically present with widespread adenopathy and frequently have bone marrow and extranodal involvement (Lymph nodes > 90%, Bone marrow 70-80%, Spleen 60%, Liver 30%, GI tract 20-30%), Peripheral blood (lymphocytosis) 20-30%)

3) GI tract involvement: °ú°Å¿¡´Â 10-20% Á¤µµ·Î »ý°¢ÇÏ¿´À¸³ª ÃÖ±Ù¿¡´Â 80-90%·Î º¸°í ÀÖÀ½

4) Most common type in GI tract: lymphomatous polyposis

5) Pathologically low-grade, clinically high-grade

6) 3-10% of all lymphoma cases

7) Mean age at presentation: 60 years

8) M:F = 3:1

9) Stage III-IV at presentation (70-80% of cases)

10) Poor prognosis: 5 years OS ¡Â 30%

11) Best treatment modality: uncertain

lymphomatous polyposis ÇüÅÂÀÇ mantle cell lymphoma


3. Mantle cell lymphoma of the GI tract

1) Most common site: ileo-cecal region

2) Any other area may be involved: from the stomach to the rectum

3) Most patients have extensive nodal and bone marrow disease at presentation

4) Symptoms: abdominal pain, diarrhea, hematochezia --> non-specific

´ÙÀå±â ħ¹üÀº ÀϹÝÀûÀÎ Çö»óÀÔ´Ï´Ù. ½ÉÁö¾î À°¾È¼Ò°ßÀÌ Á¤»óÀÎ °æ¿ì¶óµµ Á¶Á÷°Ë»ç¸¦ ÇÏ¸é ½ÊÀÌÁöÀåÀ̳ª ´ëÀå ħ¹üÀÌ ÈçÈ÷ ¹ß°ßµË´Ï´Ù.

Duodenum, stomach and colon involvement of MCL

© 2015-4-23. ÀÌÁØÇà